Rishi P. Singh, MD, FASRS

Rishi P. Singh, MD, FASRS, is vice president and chief medical officer, Cleveland Clinic Martin North and South Hospitals, and professor of ophthalmology at Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio. Singh was recently named chair of the Department of Ophthalmology at Mass General Brigham in Boston, Massachusetts, effective November 10, 2025.

Articles by Rishi P. Singh, MD, FASRS

Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME

ByDavid A. Eichenbaum, MD, FASRS,Rishi P. Singh, MD, FASRS

October 2nd 2025

Behind the scenes of building impactful educational platforms in retina care

ARVO 2025: Rishi Singh, MD, discusses real-world clinical outcomes in patients with DME

ByMartin David Harp,Hattie Hayes,Rishi P. Singh, MD, FASRS

May 5th 2025

In an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab.

Waiting on a treatment: How the history of MacTel is leading us into the future

ByRishi P. Singh, MD, FASRS

February 17th 2025

“Our current understanding of the pathophysiological basis of MacTel has led to the development of novel therapeutic approaches that may be able to break ground in this disease state.”

DR/DME: Ongoing Clinical Trials and New Diagnostic Tools

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 17th 2023

Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).

Reducing Treatment Burden of DR/DME

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 17th 2023

Diabetic retinal disease experts discuss different approaches that can reduce the treatment burden while maintaining good visual outcomes during diabetic retinopathy and diabetic macular edema (DR/DME) therapy.

Available Treatments for DR/DME

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 17th 2023

Rishi Singh, MD, provides an overview of the various treatment options available for diabetic retinopathy and diabetic macular edema (DR/DME).

Stages of DR/DME and Therapy Selection

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 10th 2023

Rishi Singh, MD, provides an overview of the stages of diabetic retinopathy and diabetic macular edema (DR/DME) and the retinal findings associated with each stage as well as factors to consider when selecting therapy.

Referring Patients With DR/DME to a Retina Specialist

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 10th 2023

Carolyn Majcher, OD, FAAO, discusses when to refer patients with diabetic retinopathy and diabetic macular edema (DR/DME) to a retina specialist.

Diagnostic Challenges of DR/DME

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 3rd 2023

Carolyn Majcher, OD, FAAO, describes challenges primary eye care providers can experience when diagnosing diabetic retinopathy and diabetic macular edema (DR/DME).

Multimodal Imaging for DR/DME

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

February 3rd 2023

Diabetic retinal disease experts discuss the standard diagnostic imaging tools that are available to detect diabetic retinopathy and diabetic macular edema (DR/DME).

Symptoms of DR/DME and Recommendations

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

January 27th 2023

Carolyn Majcher, OD, FAAO, provides an overview of the symptoms of diabetic retinopathy and diabetic macular edema (DR/DME) and recommendations for dilated eye exams for patients with type 1 and type 2 diabetes.

Prevalence of DR/DME and Impact of Early Diagnosis

ByCarolyn Majcher, OD, FAAO,Rishi P. Singh, MD, FASRS

January 27th 2023

Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss the current prevalence and future projections of diabetic retinopathy and diabetic macular edema (DR/DME) as well as the impact of early diagnosis and treatment for patients with diabetic retinal diseases.